GlassScriptPhysician profile
George Parker
NPI 1134175805
$449.19
in general payments reported to CMS, 2019-2025
13 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.15 · 2020: $47.77 · 2021: $33.41 · 2022: $36.90 · 2023: $124 · 2024: $17.54 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $124.13 | 2023 | Pinpoint |
| Abbvie INC. | $84.65 | 2019-2021 | |
| Tela Bio, INC. | $41.15 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $34.93 | 2025 | Echelon Flex |
| Becton, Dickinson and Company | $28.21 | 2025 | Arista |
| Misonix INC | $24.43 | 2019 | |
| Davol INC. | $23.75 | 2022 | |
| Medtronic, INC. | $17.54 | 2024 | Progrip |
| Merck Sharp & Dohme LLC | $15.29 | 2019 | |
| Covidien LP | $15.18 | 2020 | |
| Baxter Healthcare | $14.18 | 2020 | |
| Smith+Nephew, INC. | $13.15 | 2022 | |
| Novo Nordisk INC | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.